Fabry Screening Study

Completed

Conditions studied: Fabry Disease

In brief

To determine if patients with a deficiency of alpha-galactosidase A are at-risk for cardiac complications that commonly occur in the general population

Key facts

Study ID

NCT01019629

Run by

Baylor Research Institute

People needed

2724

Starts

2009-01-29

Expected to finish

2017-12-07

Last updated by the study team

2018-02-13

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Any diagnosis of heart disease.
• Male or Female
• Able to donate 12 cc of whole blood and 10 cc of urine

You may not qualify if…

• No diagnosis of cardiac disease.
• Unable to donate 12 cc of whole blood and/or 10 cc of urine

Where it is running

• Baylor Institute of Metabolic Disease — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.